siliconindia

For decades, drug developers have been forced to sidestep some of the most compelling disease targets in medicine simply because they were intracellular. Traditional antibodies like Humira and Keytruda are too big to cross the cell membrane and reach these targets. While small-molecule drugs can be effective, they often carry severe toxicity risks and leave physicians walking the tightrope between controlling the disease and harming the patient. Singh Biotechnology is replacing this high-stakes balancing act with a clear path to safer, more precise therapies. Founded by Dr. Sunanda Singh, M.D., Ph.D., the company has developed a proprietary class of cell-penetrating nano-antibodies that are capable of entering the cell and acting directly on intracellular proteins, offering a potential solution to diseases previously labeled ‘undruggable.’

Imagine talking to someone who forgets everything you tell them, unable to distinguish between long-term facts and recent updates. Conversations feel disjointed, and you struggle to make yourself understood. This is exactly the experience many users have with AI today. Most AI applications forget what matters, treating each interaction as new, slowing responses as token usage grows, and driving unpredictable costs. The result is frustrated users, weakened trust, and poor engagement. Businesses across sectors look for solutions that combine accuracy, scale, and memory while remaining easy to adopt. Mem0 was created to deliver exactly that. It is an open-source memory layer for AI that helps applications recall the right data at the right time, with a design inspired by how the human brain stores and retrieves information.

The global security automation market is experiencing unprecedented growth, expanding from $12.12 billion in 2025 to a projected $39.65 billion by 2034, reflecting a robust 14.08 percent compound annual growth rate. Within this booming sector, the AI-powered security compliance segment is witnessing even more dramatic expansion, surging from $188.4 million in 2024 to an expected $1.33 billion by 2034 at a 21.6 percent CAGR. As enterprises grapple with increasingly stringent regulatory frameworks across borders, a Silicon Valley startup led by an Indian-American security veteran is revolutionizing how companies approach compliance automation. Fixpliance AI, founded by exFAANG engineers, has emerged as a disruptive force in the compliance automation space, offering what the company describes as “compliance by engineers, for engineers.” The startup's private SaaS platform promises to transform the traditionally labor-intensive compliance remediation process, reducing, for example, the SOC 2 preparation time from the industry standard of four to five months to just 28 days while eliminating over 460 hours of annual engineering overhead.